-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Enliven Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2022 to Q3 2024.
- Enliven Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $80K, a 1.27% increase year-over-year.
- Enliven Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $318K.
- Enliven Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $300K, a 50% increase from 2022.
- Enliven Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $200K, a 100% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)